Clinical Trials Directory

Trials / Unknown

UnknownNCT03539926

This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).

Randomized, Controlled and Opened Trial on the Impact of the Use of a pH-Meter on the Domiciliary Control of the Urinary pH as Adjuvant to the Treatment of Cystinuric Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Devicare S.L. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the superiority of daily self-pH monitorization of Lit-control®pH meter compared to the monitorization of reactive strips (standard of care).

Detailed description

Cystinuria is a disease of autosomal recessive inheritance. This disease belongs to the so-called orphan diseases although its prevalence may change depending on the country. It is known that urinary pH is a risk factor for the formation of cystine crystals because their solubility is pH-dependent. In different studies it has been shown that the solubility of cystine in urine increases when alkalinizing urinary pH, thus reducing the likelihood of crystal formation. Therefore, the control of urinary pH along with hygienic-dietetic measures that alkalize the urine or decrease the urinary concentration of cystine (abundant intake of water, food, etc.) are highly recommended as a preventive method to prevent the formation of cystine crystals whose retention and growth results in the formation of stones. The Lit-control®pH Meter is a pH meter that allows a patient to self-monitor its urinary pH in a comfortable and simple way. With this tool the patient is able to know if his urinary pH is within the recommended limits. In other medical fields it has been observed that home monitoring of clinically relevant physiological parameters is a way of empowering the patient that can positively affect their attitudes and behaviors (adherence to received treatment, quality of life) and potentially improve their medical condition. Specifically, in patients with chronic diseases, the self-monitoring has been associated with a significant reduction in hospitalizations and hospital readmissions.

Conditions

Interventions

TypeNameDescription
DEVICELit-control®pH MeterAlkalinization products will be used as standard clinical practice together with the pH monitoring through the Lit-control®pH Meter.
DIAGNOSTIC_TESTReactive stripsAlkalinization products will be used as standard clinical practice together with the pH monitoring through the reactive strips.

Timeline

Start date
2018-04-09
Primary completion
2018-12-01
Completion
2019-02-01
First posted
2018-05-30
Last updated
2018-11-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03539926. Inclusion in this directory is not an endorsement.